References
- Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery
for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve
repair in patients with heart failure. N Engl J Med. 2018;379:2307-18.
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the
management of patients with valvular heart disease. Circulation
2021;143:e72–227.
- Baumgartner, H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for
the management of valvular heart disease. Eur Heart J
2017;38:2739–2791.
- Blasé A Carabello. The current therapy for mitral regurgitation. J Am
Coll Cardiol. 2008;52:319-26.
- Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic
mitral regurgitation: long-term outcome and prognostic implications
with quantitative Doppler assessment. Circulation. 2001;103:1759-64.
- Grossi EA, Crooke GA, DiGiorgi PL, et al. Impact of moderate
functional mitral insufficiency in patients undergoing surgical
revascularization. Circulation. 2006;114:I573-6.
- MackJM, Lindenfeld J, Abraham WT, et al. 3-year outcomes of
transcatheter mitral valve repair in patients with heart failure. J Am
Coll Cardiol. 2021;77:1029-1040.
- Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized
controlled trial of percutaneous repair versus surgery for mitral
regurgitation. J Am Coll Cardiol. 2013;62:317-28.
- Kitamura H, Kagase A, Koyama Y, et al. Early and long-term results of
surgery for secondary mitral regurgitation with a damaged heart. J
Cardiac Surg. 2019;34:919-926.
- Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus
replacement for severe ischemic mitral regurgitation. N Engl J Med.
2014;370:23-32.
- Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of
surgical treatment of severe ischemic mitral regurgitation. N Engl J
Med. 2016;374:344-53.
- Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for
chronic ischemic mitral regurgitation. Ann Thorac Surg.
2004;77:1989-97.
- Komeda M, Koyama Y, Fukaya S, Kitamura H. Papillary heads
“optimization” in repairing functional mitral regurgitation. J
Thorac Cradiovasc Surg. 2012;144:1262-4.
- Bauersachs J. Heart failure drug treatment: the fantastic four. Eur
Heart J 2021;42:681-683.
- Ellis SG, Whitlow PL, Raymond RE, Schneider JP. Impact of mitral
regurgitation on long-term survival after percutaneous coronary
intervention. Am J Cardiol. 2002;89:315-8.
- Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of
unoperated patients with severe symptomatic mitral regurgitation and
heart failure: comprehensive analysis to determine the potential role
of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63:185-6.
- Gregorevic KJ, Hubbard RE, Lim WK, Katz B. The Clinical Frailty Scale
predicts functional decline and mortality when used by junior medical
staff: a prospective cohort study. BMC Geriatr. 2016;16:117.
- Reichart D, Rosato S, Nammas W, et al. Clinical Frailty Scale and
outcome after coronary aretery bypass grafting. Eur J Cardiothorac
Surg. 2018;54:1102-1109.
- Shimura T, Yamamoto M, Kano S, et al. Impact of the Clinical Frailty
Scale on outcomes after transcatheter aortic valve replacement.
Circulation. 2017;35:2013-2024.